Modified polio vaccine extends lives in U.S. brain cancer study

More than one in five patients with an advanced brain cancer treated with a genetically modified polio vaccine were alive after three years, compared with just 4 percent who received standard treatment, according to U.S. researchers. Stuart McDill reports.

from Reuters Video: Technology https://ift.tt/2tu4Xqe